Sched.com Conference Mobile Apps
DIA 2024 Global Annual Meeting
Attending this event?
Log In
or
log in with email →
Sign Up
or
sign up with email →
Completely free and you can…
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
DIA 2024 Global Annual Meeting
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
00: Plenary
All
Forum
01: ClinSafety-PV
All
Forum
Session
Workshop
02: ClinTrials -ClinOps
All
Forum
Session
Workshop
03: Data-Tech
All
Forum
Session
Workshop
04: MedAffairs-SciComm
All
Forum
Session
Workshop
05: Patient-Focused Drug Dev
All
Forum
Session
Workshop
06: TranslationalDelivery Tech-PrecMedicine
All
Forum
Session
07: ProjectManagement-StrategicPlanning
All
Forum
Session
08: RD Quality-Compliance
All
Forum
Session
Tutorial
09: Regulatory
All
Forum
Session
Workshop
10: RegCMC-Product Quality
All
Forum
Session
Workshop
11: Statistics-Data Science
All
Forum
Session
Workshop
12: Value-Access
All
Forum
Session
Workshop
13: ProfDevelopment
All
Forum
Session
Tutorial
Workshop
14: DIAmond
All
Forum
15: Content Hubs
All
Workshop
16: Community Rounds
All
Session
17: Networking Opportunities
All
Session
Social Event
Social Evt / Reception
18: Posters
All
Session
19: InnovationTheaters
All
Session
20: Networking Opportunities
All
Session
20: Short Courses
All
Tutorial
Blood Drive
All
Social Event
Format
Forum
Session
Tutorial
Workshop
Level
Advanced
Basic
Intermediate
Featured Topics
Artificial Intelligence (AI)
Cell and Gene Therapy
Decentralized Clinical Trials (DCTs)
Digital Technology
Diversity Equity and Inclusion (DEI)
Ethics
ICH
Patient Focused
Rare Disease
Real-World Data (RWD)- Real-World Evidence (RWE)
Regulator Perspectives
Regulatory Collaboration
Regulatory Reliance
Risk Management
Special Populations
Student Programming
menu
Menu
Schedule
Speakers
Search
LL
Lara Lane
Ironwood Pharmaceuticals, United States
Director, Clinical Operations
Samantha Lane
Drug Safety Research Unit, United Kingdom
Head of Research, Centre of Pharmacovigilance Sciences
Connie Langer
Pfizer Inc, United States
Senior Director
Juan Lara
Centre For Innovation In Regulatory Science, Mexico
Senior Research Analyst
Joseph Laudano
IQVIA, United States
Medical Director
Marion Laumonier
World Health Organization (WHO), Switzerland
Technical Officer, Regulatory Convergence and Networks
Anthony Lawler
Therapeutic Goods Administration, Australia
Deputy Secretary, Health Products Regulation Group
Cathryn Lee
FDA, United States
Director, Office of Program Operations, PDIMS, OND, CDER
Charles Lee
AstraZeneca, United States
Executive Regulatory Science Director
Jennifer Lee
FDA, United States
Senior Health Scientist, Oncology Center of Excellence
Kerry Jo Lee
FDA, United States
Assoc. Dir. for Rare Diseases; Program Manager, Advancing Rare...
Mark Lee
N-Power Medicine, United States
CEO
Sau Lee
FDA, United States
Deputy Super Office Director, OPQ, CDER
HV
Hans van Leeuwen
Astellas Pharma Europe BV, Netherlands
Head of Regulatory Operations
ML
Michael Lehmicke
Alliance for Regenerative Medicine, United States
Senior Vice President, Science and Industry Affairs
Catherine Lerro
FDA, United States
Senior Pharmacoepidemiologist, Oncology Center of Excellence
Anastasia Lesogor
Novartis Pharma AG, Switzerland
Senior Global Program Clinical Program Head
Char Leung
Genmab, United States
Director, Development Program Management
Bennett Levitan
Janssen Research & Development LLC, United States
Senior Director, Benefit-Risk Assessment, Global Epidemiology
Emily Lewis
UCB, United States
Artificial Intelligence and Innovation Lead, Neurology
LL
Lily Li
Metaverse Law, United States
Founder and President
Carsten Linnermann
Neogene Therapeutics, AstraZeneca Group, Netherlands
Chief Executive Officer
Craig Lipset
Clinical Innovation Partners, United States
Managing Partner
Ke Liu
Marengo Therapeutics, United States
Chief Development Officer
Qi Liu
FDA, United States
Assoc Director for Innovation and Partnerships, OCP, OTS, CDER
TJ
Tong (Jenny) Liu
US Pharmacopeia, United States
Principal Scientist
CL
Catherine Lockhart
Biologics and Biosimilars Collective Intelligence Consortium, United States
Chief Science Officer
Infosys Technologies Ltd.
United States
Shun Lu
Shanghai Jiaotong University, China
Director, Center for Clinical Medicine of Lung Cancer, Shanghai Chest...
Jingyu (Julia) Luan
AstraZeneca, United States
Executive Regulatory Science Director, BioPharmaceuticals R&D
Tyler Ludlow
Decision Skills Institute, United States
Founder and Chief Decision Scientist
Yuan Luo
National Institute on Aging, NIH, United States
Program Director, AD/ADRD Biomarkers, Division of Neuroscience
Sarah Lyons
IQVIA, Canada
Vice President, Data Transformation and AI Platforms, DTA and AI
Liyang Lyu
University of Macau, Macao
Student
Rebecca Lyzinski
JMP Statistical Discovery, United States
Senior Software Developer
Gary Ma
Taimei Technology Inc., United States
President
Tara MacCannell
Vertex, United States
Global Head, RWE
Currien MacDonald
WCG, United States
Medical Chair Director
Demetra Macheras
AbbVie, United States
Director, Regulatory Policy and Intelligence - Regulatory Affairs
Christina Mack
IQVIA, United States
Chief Scientific Officer, Real-World Solutions
Subha Madhavan
Pfizer Inc, United States
Vice President and Head of AI/ML, Global Biometrics and Data...
Laura Magda
SRI International, United States
Director of Clinical Trials
Nicole Mahoney
Novartis Pharmaceuticals Corporation, United States
Executive Director US Regulatory Policy & Intelligence
Kausik Maiti
Parexel International , India
Executive Director, Safety Medical Sciences
Antara Majumdar
GlaxoSmithKline, United States
Director, Oncology Statistics
JM
Jennifer Malinowski
Johnson & Johnson Innovative Medicine, United States
Director, Access and Policy Research
Subhro Mallik
Infosys, United States
EVP - Global Head of Life Sciences
VM
Vandana Mandavilli
Northeastern University, United States
MS Regulatory Affairs Student
Sri Mantha
FDA, United States
Director, Office of Strategic Programs, CDER
AM
Angelika Manthripragada
Regeneron, United States
Director, Pharmacoepidemiology, Global Patient Safety
Anabela Marcal
European Medicines Agency, Netherlands
EMA Liaison Official to the US FDA
Peter Marks
FDA, United States
Director, Center for Biologics Evaluation and Research
AM
Andrew Marley
Parexel, Spain
Senior Epidemiologist
Allison Martin
Sanofi, United States
Director, Regulatory Science and Policy, North America
Eddilisa Martin
M&B Sciences Inc., United States
Co-Founder and Chief Executive Officer
Hotaka Maruyama
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Division of PharmacoEpidemiology, Office of Pharmacovigilance ?
Rosana Mastellaro
Sindusfarma, Brazil
Director, Technical Regulatory Affairs and Innovation
JM
Julia Maues
Patient-Centered Dosing Initiative, United States
Patient Advocate
Alex May
District of Columbia, United States
North America Lead - Regulatory Science, Policy, & Intelligence
Christine Mayer-Nicolai
Merck Healthcare KGaA, Germany
Vice President, Regulatory and Scientific Policy
Susan Mayo
FDA, United States
Senior Mathematical Statistician, CDER Office of Biostatistics
Christy Mazzarisi
Network Partners Group, United States
Quality COE Lead
Cortez McBerry
NDA Partners, United States
Partner
Sorcha McCrohan
DIA, United States
Specialist, Scientific Programs
DM
Dezbee McDaniel
Clinispan Health, United States
CEO/Co-Founder
SM
Sarah McKeown-Cannon
Publicis Health, United States
Vice President, Growth
Lindsay McNair
Equipoise Consulting, United States
Principal Consultant
Melodi McNeil
AbbVie, United States
Director, Regulatory Policy and Intelligence
David Meats
Certara, United States
Director, Regulatory Services Management
NM
N-Power Medicine
United States
Kevin Meek
PCM Trials, United States
Director, Supply Chain Operations
Munish Mehra
Tigermed, United States
Managing Director, Principal Biostatistician
Timothe Menard
F. Hoffmann-La Roche Ltd, Switzerland
Global Head, Quality Excellence Digital | Bioethics Coach (Data...
Lubna Merchant
Pfizer Inc , United States
Director, Risk Management Center of Excellence
Danielle Metzger
Network Partners Group, United States
Consultant
Joe Miles
UiPath, United States
Industry Director, Life Sciences
Alexis Miller
Merck & Co., Inc., United States
Acting Global Lead, Global Regulatory Policy and Intelligence
Jennifer Miller
Yale School of Medicine, United States
Associate Professor of Medicine; Co-Director, Program for Biomedical...
Jessica Miller
GlaxoSmithKline, United States
1st-Year Fellow, Global Regulatory Affairs CMC
SM
Sam Miller
Exploristics, United Kingdom
Head of Strategic Consulting
Sandy Milligan
Innovex Strategies, United States
Board of Director Member, Gossamer Bio; Principal
Pallavi Mishra-Kalyani
FDA, United States
Deputy Division Director, DBV, OB, CDER
Lauren Misztal
Clario, United States
SVP, General Counsel
Marian Mitroiu
Biogen, Switzerland
Associate Director Biostatistics
Namosha Mohite
Bayer, United States
Assistant Director, US Regulatory Affairs Liaison
Martha Monser
FDA, United States
Consumer Safety Officer, Office of Regulatory Operations, CBER
MM
Michael Monteleone
FDA, United States
Associate Director for Labeling, OND, CDER
Yola Moride
YolaRX Consultants, Canada
President
Susan Morris
Susan Morris Coaching, United States
Professional Coach and Personal Growth Speaker
Rania Mouchantaf
Health Canada, Canada
A/Executive Director, Marketed Pharmaceuticals Bureau, MHPD
Lan Mu
Bio-Thera Solutions, United States
Senior Vice President
David Mukanga
Bill & Melinda Gates Foundation, United States
Deputy Director, Africa Regulatory Systems
Leyna Mulholland
Transent Group, United States
Executive Director, Global Regulatory Affairs
Joe Mullen
SciBite, United Kingdom
Head of Data Science and Professional Services
Theresa Mullin
FDA, United States
Associate Center Director - Strategic Initiatives, CDER
AM
Alissa Mun
FDA, United States
Health Scientist Policy Analyst, OMP, CDER
Monica Munoz
FDA, United States
Division Director, Division of Pharmacovigilance-I, OSE, CDER
Melvin Munsaka
AbbVie, United States
Senior Director, Head Safety Statistics
Nancy Myers
Catalyst Healthcare Consulting, Inc, United States
CEO and Founder
Jane Myles
Decentralized Trials and Research Alliance (DTRA), United States
Program Director
Sridevi Nagarajan
AstraZeneca , United Kingdom
Head, Digital Regulatory Strategy
DN
David Nahamya
Uganda National Drug Authority, Uganda
Secretary to the Authority
Bijan Najafi
Baylor College of Medicine, United States
Professor of Surgery; Director, Clinical Research
Mehdi Najafzadeh
Medidata AI, United States
Senior Director
TS
Tejendra Sri Ajith Nalluri
Northeastern University, United States
MS Regulatory Affairs Student
Rohit Nambisan
Lokavant, United States
CEO & Co-Founder
Vidya Narayanaswamy
IPM, United States
Consultant
Sharmin Nasrullah
Salesforce, United States
General Manager, Life Sciences, Clinical
Edward Neilan
National Organization for Rare Disorders (NORD), United States
Chief Medical and Scientific Officer
Robert Nelson
Johnson & Johnson, United States
Executive Director, Pediatric Drug Development (CHILD)
Nancy Ngum
University of Hertfordshire, United Kingdom
Student
Christiane Niederlaender
Parexel International, United Kingdom
Vice President, Technical
Hubert Niewiadomski
Cledar, United States
Chief Executive Officer
IN
Ifeoma Njubigbo
University of Illinois Chicago, United States
PharmD Student
Yoshiaki Nodera
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Principal Inspector, Office of Non-clinical and Clinical Compliance I
Lorraine Nolan
Health Products Regulatory Authority , Ireland
Chief Executive
Karen Noonan
Association of Clinical Research Organizations (ACRO), United States
Senior Vice President, Global Regulatory Policy
BN
Bridget Nugent
FDA, United States
Science Policy Analyst
Perla Nunes
Community Outreach and Clinical Research DEI Consultant, United States
Patient Advocate
CO
Catina O'Leary
Health Literacy Media, United States
President and Chief Executive Officer
Heiner Oberkampf
ACCURIDS, Germany
CEO
Ashley Ogawa-Wong
Merck Sharp & Dohme LLC, United States
Associate Director, Regulatory Liaison
John Okudjeto
Janssen Research & Development LLC, United States
Manager, Pharmacovigilance QA
Lauren Oliva
Biogen, United States
US Lead, Global Regulatory Policy
Carlos Orantes
Alcanza Clinical Research, United States
Chief Executive Officer
John Overington
Exscientia, United Kingdom
Chief Data Officer
Mercy Owusu-Asante
University of Hertfordshire, United Kingdom
Graduate Student, School of Life and Medical Sciences
Chelsea O'Connell
Amgen, United States
Director, Global Regulatory Policy & Intelligence
Catina O'Leary
Health Literacy Media, United States
President and Chief Executive Officer
Ana Padua
EMD Serono, Switzerland
Director EU Global Regulatory and Scientific Policy
Lee Pai-Scherf
FDA, United States
Senior Physician, GCP Assessment Branch, DCCE, OSI, OC, CDER
Chockalingam Palaniappan
Life Sciences Innovation Executive, United States
Gerald Dal Pan
FDA, United States
Director, Office of Surveillance and Epidemiology, CDER
Herbert Pang
Genentech, A Member of the Roche Group, United States
Expert Statistical Scientist
Raphael Pareschi
Roche, Brazil
Patient Safety Lead/ Head of Pharmacovigilance Brazil
Megan Parisi
Syneos Health, United States
Patient Solutions Lead
JP
Jay Park
Core Clinical Sciences, Canada
Scientific Lead and Founder
CP
Connie Pascual
Merck & Co., Inc., United States
Principal Scientist, Regulatory Digital Health
MP
Mayur Patel
AstraZeneca, United States
Vice President, Oncology Therapy Area, Global Patient Safety
NP
Nital Patel
Consultant, United States
Miya Paterniti
FDA, United States
Lead Physician, Division of Pulmonology, Allergy, and Critical Care,...
Vandana Pathak
Amgen, United States
Director Global Regulatory Affairs
Rajneesh Patil
IQVIA, United States
Vice President, Clinical Operations
EP
Elizabeth Patterson
Synterex, Inc., United States
Business Operations Associate
David Pearce
Sanford Health, United States
President of Innovation and Research/Chair International Rare...
Doug Peddicord
ACRO, United States
Executive Director
IP
Izabela Pedro
Hospital Israelita Albert Einstein, Brazil
Clinical Research Associate
Y. Veronica Pei
FDA, United States
Acting Associate Director, Biomedical Informatics and Regulatory...
MP
Michael Pelosi
Astellas, United States
Director, Quality Analytics
KP
Keerthi Pendri
Northeastern University, United States
MS Regulatory Affairs Student
Ana Zanoletty Perez
European Medicines Agency, Netherlands
Head of Clinical Trials Transformation Workstream
Vada Perkins
Boehringer Ingelheim, United States
Vice President, Global Head of Regulatory Intelligence & Policy
Wesley Peters
Evidera/Thermo Fisher Scientific, United States
Research Specialist II, Patient Experience
MP
Mark Peterson
Vertex Pharmaceuticals, United States
Senior Director, Modeling and Simulation
Lionel Phillips
Inside Edge Consulting, United States
President
Francesco Pignatti
European Medicines Agency, Netherlands
Scientific Adviser for Oncology
Maria Cristina Mota Pina
AbbVie, United States
Head, Regulatory Policy for Emerging Markets -Japan and Australia
Agustin Brito Del Pino
Pfizer Inc, Uruguay
Regional Regulatory Hub Team Lead
Gino Pirri
PPD, part of Thermo Fisher Scientific, United States
VP Head Product & Technology
Laura Pizzi
ISPOR, United States
Chief Science Officer
Jagdeep Podichetty
Critical Path Institute, United States
Senior Director of Predictive Analytics
Grzegorz (Greg) Podrygajlo
CSL Behring, Switzerland
GRA CMC Director, Head of Global Manufacturing Support
Elena Polverejan
Johnson & Johnson, United States
Scientific Director, Statistical Modeling and Methodology, Statistics...
Vaishali Popat
FDA, United States
Branch Chief, Office of Clinical Evaluation,Office of Therapeutic...
Douwe Postmus
University Medical Center Groningen & EMA, Netherlands
Assistant Professor & Seconded National Expert
GP
Gregory Powell
GlaxoSmithKline, United States
Senior Director, Safety and Clinical Innovation
Sarah Powell
Powell Regulatory Services, United States
President
DP
Douglas Pratt
FDA , United States
Supervisory Medical Officer, OVRR, CBER
Regina Lynn Preciado
Content Rules, Inc., United States
Senior Director of Content Strategy Solutions
Scott Proestel
FDA, United States
Senior Medical Officer, ODES, OND, CDER, FDA
Raviv Pryluk
PhaseV, United States
Rose Purcell
Takeda, United States
Director, Global Regulatory Policy and Innovation
Kim Quaintance-Lunn
Bayer AG, United States
Vice President, Regulatory Affairs Americas
Kim Quaintance-Lunn
Alexion, United States
Vice President, Head of Regulatory Science and Execution
AR
Adriana Racolta
Pfizer Inc, United States
Director, Regulatory Affairs, Companion Diagnostics
Sophie Radicke
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
Christine Von Raesfeld
The Light Collective, United States
Founder/SME, Patient Experience
Motiur Rahman
FDA, United States
Senior Epidemiologist, Real World Evidence Analytics, OMP, CDER
Prasanna Rao
Pfizer Inc, United States
Sr. Director, Global Head, AI/ML, Clinical Data Sciences
Rita Redberg
UCSF Medical Center, United States
Director, Women's Cardiovascular Services; Professor of Medicine
Sara Reed
Consultant, United States
Video Production
Chara Reid
Cencora (formerly AmerisourceBergen), United States
Director, Specialty Practice Network, Immunology
Ilona Reischl
Austrian Medicines and Medical Devices Agency (AGES MEA), Austria
Biologics Quality Assessor
Kim Ribeiro
AbbVie, United States
Head, Diversity and Patient Inclusion, Clinical Development Solutions
Brandon Rice
Weave, United States
Chief Product Officer
Margaret Richards
Panalgo, United States
Executive Director, Solutions
James Riddle
Advarra, United States
Senior Vice President, Global Review Operations
Sydney Ringold
Cytel, Inc., United States
Customer Success Manager
Gerd Rippin
IQVIA, Germany
Senior Director, Biostatistics, Real-World Solutions
MaryAnne Rizk
Rizk Management Advisors, United States
Chief Executive Officer
Amanda Roache
Pharmaceutical Research and Manufacturers of America (PhRMA), United States
Senior Director, Science and Regulatory Advocacy
John Roberts
Vyant Bio, Inc., United States
President and Chief Executive Officer
Tracey Robertson
Boehringer Ingelheim Pharmaceuticals Inc., United States
Head of Patient and Site Engagement Capabilities
Laura Rodwell
Dutch Medicines Evaluation Board, Netherlands
Statistical Assessor
LR
Liz Rogers
Pfizer , United States
Head of Global Site and Study Operations
Michelle Rohrer
Genentech Roche, United States
Senior Vice President, Global Head of Product Development Regulatory...
Michelle Rohrer
Genentech, A Member of the Roche Group, United States
Senior Vice President, Global Head of Product Development Regulatory...
Maria Antonieta Roman
Novartis, Mexico
Head Regulatory Policy Emerging Markets LATAM
Josh Rose
Hawthorne Effect, United States
Chief Executive Officer
Michael Rosenblatt
Greenhouse Consulting, United States
Managing Director
1
2
3
4
5